Policy moves fast. You shouldn’t have to chase it.
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.
The cannabis industry is watching Texas with the intensity of a death row appeal as the state's Legislature defies Governor Abbott's push for hemp regulation and advances toward outright prohibition. It's a constitutional showdown that could determine whether hemp survives in conservative America or gets relegated to blue-state sanctuaries.
📧 Send it to your counsel.
🗳️ Share it with your lobbyist.
⚖️ Read it before the vote.
Know more. Move faster. Win smarter.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: The Texas Senate State Affairs Committee passed a near-total THC ban 10-0 on Tuesday, directly defying Governor Abbott who vetoed a similar bill last month and called for regulation instead of prohibition (Dallas News). Senate Bill 5 by Sen. Charles Perry would criminalize all consumable hemp products containing any amount of THC, affecting the state's $8 billion industry with 8,500 licensed retailers. Law enforcement officials argued regulation would be "expensive, complicated, and difficult to enforce," with Allen Police Chief Steve Dye saying "no amount of personnel or resources" could effectively manage the industry. Veterans and retailers pushed back, with Texas VFW's legislative director calling the ban "about the pharmaceutical lobby" and "the alcohol lobby" rather than public safety. Related: Abbott Details Texas Hemp Regulation Plan in Special Session
💡 Why It Matters: This sets up a direct constitutional confrontation between Texas's executive and legislative branches over one of the nation's largest hemp markets. Abbott wants to regulate hemp products similarly to alcohol, with age restrictions, licensing requirements, and dosage limits, calling prohibition approaches "absurd." The Legislature argues that regulation legitimizes what they consider "unregulated recreational marijuana" and violates conservative principles. The economic stakes are enormous. Texas has the second-largest hemp market in the nation, and a prohibition would eliminate thousands of jobs and millions in tax revenue while potentially driving consumers to illicit markets.
The political dynamics reveal deeper tensions within the Republican Party over drug policy. Abbott represents a pragmatic, business-friendly approach that acknowledges consumer demand and federal hemp legalization under the 2018 Farm Bill. The Legislature reflects traditional drug war conservatism that views any intoxicating substance as inherently dangerous. This divide mirrors national Republican splits between libertarian-leaning governors who prioritize economic growth and social conservatives who prioritize prohibition.
🧠 THC Group Take: Cole's past statements about cannabis dangers provide every reason for skepticism, but federal cannabis policy ultimately depends on Donald Trump's calculations. The White House has hinted that reform is coming, yet the industry needs to prepare for the reality that Schedule 3 isn't the regulatory panacea it appears to be. Moving cannabis to medicine status brings FDA oversight, Good Manufacturing Practices, clinical trial requirements, and prescription-only access that could strangle state adult-use programs. The real question isn't whether rescheduling happens, but whether an industry that has generated $50 billion in legal sales and created hundreds of thousands of jobs gets the legitimacy it has earned through market performance and regulatory compliance. State operators have proven they can run sophisticated, compliant businesses under impossible federal constraints. They deserve a regulatory framework that acknowledges this track record rather than forcing them into a pharmaceutical model designed for pills, not plant medicine.
Fast-moving headlines, flagged for what matters.
The Senate confirmed Terrance Cole as permanent DEA Administrator by a narrow 50-48 vote, placing the stalled cannabis rescheduling process squarely in his hands (Business of Cannabis). The 22-year DEA veteran told lawmakers that reviewing the rescheduling process would be "one of my first priorities" but stopped short of endorsing the proposed Schedule III move, citing a need to "look at the science" and "listen to the experts". The DEA reported in July that no progress had been made in six months on rescheduling, attributing delays to temporary leadership under Acting Administrator Robert Murphy. Cole's confirmation removes the leadership vacuum that has paralyzed the process since January, though his cautious statements suggest he may take a methodical approach rather than rushing toward Biden's proposed Schedule 3 classification. The industry now waits to see whether Cole will accelerate the timeline or conduct his own comprehensive review. Related: Cannabis Industry Weighs In on New DEA Chief
VA Secretary Doug Collins told Newsmax he's "very open" to expanding psychedelic therapy for veterans, emphasizing he wants to "heal people" and "see cures" rather than just long-term treatments (Marijuana Moment). Collins revealed VA is conducting about a dozen clinical trials on "various different substances" including MDMA-assisted therapy at VA Bronx with "really, really good results". The secretary acknowledged that "a lot of it is still tied up with regulation in the federal government" but said VA is working with HHS to move forward so veterans don't have to "go elsewhere, out of country" for treatments. Collins is coordinating with HHS Secretary RFK Jr., who said his aim is to "free up plant-based medicine options within 12 months". The VA secretary's aggressive push for psychedelic access represents one of the most supportive federal positions on alternative therapies, despite regulatory constraints that continue to limit veteran access to promising treatments.
Missouri cannabis regulators began unannounced visits to cultivation and manufacturing facilities on July 1st, collecting products to test at the state public health lab for mold, pesticides, and other contaminants (News from the States). Testing unit manager Ryan Bernard assured operators this "won't impact business" and products can continue moving through the supply chain during sampling. The program starts with about 50 products monthly, using $2.4 million in state funding allocated for the division's first attempt to audit private testing labs. While regulators expect clean results, national testing experts warn Missouri might be "shocked" by what they find when independently verifying the work of for-profit labs. The initiative mirrors growing state concerns about "lab shopping" where operators seek the most favorable test results rather than the most accurate ones.
The Missouri Supreme Court ruled 6-1 that cities and counties cannot both impose 3% marijuana sales taxes, defining "local government" to mean only one municipality can tax in a given area (Missouri Independent). The decision focused on a Florissant dispensary where customers paid nearly 21% total sales tax from both city and county levies, impacting over 70 areas statewide where governments were double-taxing. The ruling will save Missouri cannabis customers an estimated $3 million monthly, with the trade association arguing customers "already pay their fair share" as tax revenue has tripled state estimates. St. Charles County Executive Steve Ehlmann criticized the constitutional amendment process, saying if this were "just a regular law," the legislature could have fixed the ambiguity instead of leaving it to the courts. The decision clarifies that incorporated areas get city taxes while unincorporated areas get county taxes, but not both.
Alabama Medical Cannabis Commission members are fighting a federal lawsuit filed by Alabama Always LLC, which claims commissioners violated the company's First and Fourteenth Amendment rights by retaliating after it criticized the flawed licensing process (Alabama Political Reporter). The company alleges it was repeatedly denied licenses despite meeting qualifications, with commissioners retaliating for legal challenges pointing out violations of Alabama cannabis law. Alabama's medical cannabis program has been mired in litigation since June 2023, with multiple licensing do-overs, emergency rules being voided by courts, and accusations of political favoritism. The federal case adds constitutional claims to an already chaotic rollout where commissioners have been accused of awarding licenses to unqualified companies while freezing out critics. Alabama remains the only state where a medical cannabis program has generated more lawsuits than patients served.
Tennessee Governor Bill Lee signed House Bill 1376 on May 21st, transferring hemp-derived cannabinoid regulation from the Agriculture Department to the Alcoholic Beverage Commission and banning THCA and synthetic cannabinoids effective January 2026 (Memphis Business Journal). For the first time, alcohol-licensed establishments will have a clear legal pathway to sell hemp products on-site, while convenience stores and grocery stores are banned from sales. The law prohibits direct-to-consumer sales, requiring all transactions be face-to-face, and sets strict dosage limits including 15mg for beverages with maximum two servings per container. Implementation has been delayed by ongoing litigation, with a court injunction preventing rules from taking effect until at least February 2025 pending expert testimony on testing requirements. The overhaul represents one of the most restrictive hemp laws in the country, essentially treating hemp products like alcohol while eliminating the popular THCA market that had operated in regulatory gray areas.
Democratic lawmakers reintroduced the SHIP Act allowing small cannabis cultivators and manufacturers to ship directly to consumers across state lines via USPS and commercial carriers once federal prohibition ends (Marijuana Moment). The bill defines small cultivators as those growing up to one acre outdoors or 5,000 square feet indoors, while manufacturers must have under $5 million in gross annual revenue. Reps. Jared Huffman and Val Hoyle designed the legislation to help small growers compete against multi-state operators who have resources to quickly expand when federal legalization arrives. The bill includes age verification requirements and clarifies that prohibition states can't block cannabis shipments crossing their borders, though they can maintain their own bans. Industry advocates warn that without direct-to-consumer shipping, "federal cannabis legalization risks reinforcing" market consolidation instead of correcting it. The proposal essentially treats cannabis like craft beer or wine, giving small producers a fighting chance against corporate giants.
Leading cannabis researcher Ryan Vandrey delivered a stark rebuttal to prohibition advocates at a federal SAMHSA webinar, declaring that youth marijuana use has remained "relatively stable" or declined even as adult legalization spreads (Marijuana Moment). Using California data since 1996, the Johns Hopkins professor showed "really no change" in consumption rates among eighth, 10th, or 12th graders, with recent years showing actual decreases. This mirrors multiple JAMA studies finding no evidence that adult-use laws increase teen consumption. The timing matters: as federal rescheduling debates heat up, having a respected researcher torpedo the "gateway to teen use" argument at a federal health meeting signals shifting scientific consensus within government circles where policy gets made. Vandrey's presentation essentially gave federal health officials permission to stop worrying about the youth access boogeyman that has dominated prohibition talking points for decades.
The deeper pattern behind today’s moves — and why it matters next.
🧾 Context: The alcohol industry faces an unprecedented challenge as cannabis beverages emerge from niche curiosity into legitimate market threat. Daily marijuana use surpassed daily alcohol consumption in 2022, with roughly 17.7 million cannabis users compared to 14.7 million daily drinkers, while nearly half (49%) of Americans plan to drink less alcohol in 2025. The cannabis beverage market, valued at $1.16 billion in 2023, is projected to reach $3.86 billion by 2030. During Dry January, cannabis retailers report beverage sales increasing up to 50 percent as consumers seek alternatives that "relax & unwind without the hangover".
🔎 What It Signals: This signals a fundamental shift in how Americans think about social intoxication, with Big Alcohol responding through three distinct strategies. Partnership investments like Constellation's $4 billion bet on Canopy Growth mostly failed, with Constellation later writing off the investment and stating they are "not interested in investing in non-beer and spirits assets going forward". More promising is regulatory capture: Wine & Spirits Wholesalers of America became the first alcohol trade association to advocate for federal cannabis legalization, specifically "by applying regulations similar to those implemented for alcohol". The industry is also pushing non-alcoholic innovation, with sales hitting $565 million in 2023, a 35% increase.
🧠 THC Group Take: Market share matters less than consumer motivation in this generational shift. Alcohol brings $541 million in lobbying expenditures and nearly a century of regulatory sophistication, the kind of institutional knowledge that built empires on understanding exactly how much Americans will pay to feel different. Cannabis brings something more dangerous: consumer momentum already trimming beer sales by 0.7 percentage points in legal states, driven by people who actively reject what alcohol represents.
The industry that spent decades helping criminalize cannabis now seeks to control its commercialization through regulatory frameworks that mirror alcohol's three-tier distribution system. If you're in the hemp beverage space, you should be preparing for federal regulations designed by alcohol lobbyists rather than cannabis operators, a system built to favor existing power structures over innovation. If you're a policymaker or regulator that has warned against regulatory capture, it is happening in real time before the market even matures, and those democratic processes you've built to ensure market access are about to turn into bidding wars between old money and new.
The ultimate irony runs deeper than market competition: an industry built on regulatory barriers now faces a competitor whose primary appeal is being everything those barriers were designed to suppress.
From the hearing room to the comment section — we’re watching it all.
🍦 A Maine ice cream maker pleaded guilty to federal charges after his unlabeled THC "coffee Oreo" ice cream sent four New Hampshire customers to the hospital, with victims thinking they were having strokes (Boston Globe). New Hampshire remains the only New England state without legal cannabis, though apparently not without accidental dosing.
🐛 Cannabis growers are ditching pesticides for tiny assassins like ladybugs, parasitic wasps, and nematodes that crawl inside pests and devour them from the inside out (High Times). Cannabis agriculture now officially worries about yeast, mold, and bugs—though in this case, the bugs are the solution.
🌿 The Fresh Toast declares August "National Wellness Month" and asks whether cannabis should be part of your daily wellness routine, alongside sleep hygiene and mindfulness practices (The Fresh Toast). Cannabis has officially graduated from counterculture to self-care as grandma’s wellness routine now includes CBD gummies and meditation apps.
🌾 South Dakota farmers are embracing hemp as a way to revitalize small towns and sequester carbon, with the state becoming the nation's top hemp producer despite growing only 3,700 acres (Marijuana Moment). Rural America discovers that the plant once demonized might actually save their communities…and the climate.
🌿 The cannabis industry generates 7,000-10,000 tons of plastic waste annually, with a gram of cannabis requiring "up to 70 times its weight in packaging materials" due to child-resistant and tamper-proof requirements (Newsweek). Legal cannabis has created its own environmental paradox: an industry built on a plant now buried under mountains of regulatory plastic.
